Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

GENERAL (Narrative) (Details)

v3.23.1
GENERAL (Narrative) (Details)
$ / shares in Units, $ in Thousands, ₪ in Millions, $ in Millions
 1 Months Ended 12 Months Ended
Mar. 08, 2023
Nov. 07, 2022
CAD ($)
Apr. 06, 2022
CAD ($)
May 10, 2021
CAD ($)
Shares
May 10, 2021
USD ($)
Shares
$ / shares
shares
Aug. 19, 2022
CAD ($)
shares
Aug. 19, 2022
USD ($)
shares
Jan. 31, 2022
CAD ($)
Dec. 31, 2022
CAD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2020
CAD ($)
Oct. 11, 2022
CAD ($)
Oct. 11, 2022
ILS (₪)
Jan. 31, 2022
ILS (₪)
Dec. 31, 2019
CAD ($)
Disclosure of subsidiaries [line items]                                
Number of shares issued | shares                 7,569,526   6,811,620          
Proceeds from issuing shares                 $ 3,756   $ 28,131 $ 0        
Cash and cash equivalents   $ 406             2,449   13,903 8,885       $ 13,926
Borrowings, interest rate                         15.00% 15.00%    
Borrowings                         $ 4,050 ₪ 10.5    
Working capital of business acquisition                 1,147              
Net loss for the year                 (30,791)   (23,035) [1] $ (8,245)        
Lender charges                 4,875              
Impairment of investment   $ 17,959                            
Share capital issuance cost                 $ 178   $ 3,800          
Workforce reduction description Company expects to reduce its workforce in Israel by 20%-25% across all functions (including executives).                              
Private Placement [Member]                                
Disclosure of subsidiaries [line items]                                
Number of shares issued | shares           599,999 599,999   599,999              
Proceeds from issuing shares           $ 6,500 $ 5   $ 3,756 $ 3            
Share capital issuance cost           $ 178     178              
Sde Avraham Cultivation Facility [Member]                                
Disclosure of subsidiaries [line items]                                
Restructuring expenses     $ 4,383                          
Trichome Financial Corp. (“Trichome”) [Member] | Revolving Credit Facility [Member]                                
Disclosure of subsidiaries [line items]                                
Borrowings                 5,084              
Mizrahi [Member] | Revolving Credit Facility [Member] | Focus Medical Herbs Ltd [Member]                                
Disclosure of subsidiaries [line items]                                
Total Commitment               $ 6,000             ₪ 15.0  
Borrowings, interest rate basis               Prime interest rate plus 1.5% (6.25% per annum as of December 31, 2022).                
Tjac And Certain Mym Subsidiaries [Member]                                
Disclosure of subsidiaries [line items]                                
Cash and cash equivalents                 2,449              
Net cash used in operating activities                 12,340              
Net loss for the year                 $ 30,791              
Overnight Marketed Offering [Member]                                
Disclosure of subsidiaries [line items]                                
Par value per share | $ / shares         $ 57.5                      
Number of shares issued | shares         608,696                      
Proceeds from issuing shares       $ 42,502 $ 35                      
Number of warrants issued for common shares | Shares       45,652 45,652                      
[1] Reclassified in respect of discontinued operations - see Note 24.